IMHRO Rising Star Award
Colleen McClung, PhD Receives Johnson & Johnson / IMHRO Rising Star Translational Research Award
Each year the International Mental Health Research Organization (IMHRO), in collaboration with Johnson and Johnson's Corporate Office of Science and Technology (COSAT), presents up to two awards to highly talented translational scientists whose research focuses on working toward novel therapies for psychiatric illness. Dr. Colleen McClung, Associate Professor of Psychiatry, received one of the awards for her proposal to find an improved mood stabilizer through two sets of mice experiments. The experiments, which build on her previous research, aim to determine whether and how both the drug MS-275 and the knock-down effect of specific HDAC genes may effectively treat manic behaviors. The award will provide Dr. McClung with a grant of $250,000 in direct program costs over a three year period to conduct her research.